Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-06-08 00:00:00 ET · period of report 2022-06-07 · accession 0000899243-22-021477 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-08 | 2022-06-07 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $5.76 | -2,542 | 630.9K | -0.4% | -$14.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-07 | S | D | 2,542 | $5.76 | 630,906 | D | — | — |